Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Our starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. This is a conviction that is embedded in our investment strategy since it necessitates a deeper understanding and reduces risks. This way, Impilo invests in people’s opportunities to enjoy healthier lives in the future.
Looking for a particular Impilo employee's phone or email?
The Impilo annual revenue was $5.2 million in 2026.
Jesper Eliasson is the CFO of Impilo.
33 people are employed at Impilo.
Impilo is based in Stockholm, Stockholm.
The NAICS codes for Impilo are [523, 5239, 52392, 523920, 52].
The SIC codes for Impilo are [62, 628].